Advertisement

The Latest

Michel Orsinger, CEO of Synthes, recently received $52 million as a result of Johnson & Johnson's acquisition of the company, if the deal closes sometime over the next two years, according to a Philadelphia Inquirer report.

Pain management is a specialty in flux. Not only are more chronic pain sufferers seeking out treatment, but the release of a recent Center for Disease Control report, which found more people die from prescription drug overdoses than heroin and…

Lawrence Dorr, MD, founder of the Dorr Arthritis Institute at Good Samaritan Hospital in Los Angeles, recently published a novel titled Die Once, Live Twice, detailing the history of medicine, according to a story from Authorlink.

Decision Resources, a pharmaceutical and healthcare research and advisory firm, found therapies to treat chronic back pain and arthritis pain will continue to be the most profitable segments of the chronic pain drug market through 2020, according to a news…

Advertisement